Literature DB >> 22585693

Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms.

Richard A Larson.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22585693     DOI： 10.1200/JCO.2011.41.1215

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  The evolving challenge of therapy-related myeloid neoplasms.

Authors:  Jane E Churpek; Richard A Larson
Journal:  Best Pract Res Clin Haematol       Date:  2013-10-01       Impact factor: 3.020

Review 3.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

4.  Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

Authors:  A M Zeidan; N Al Ali; J Barnard; E Padron; J E Lancet; M A Sekeres; D P Steensma; A DeZern; G Roboz; E Jabbour; G Garcia-Manero; A List; R Komrokji
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

Review 5.  Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia.

Authors:  Ram Vasudevan Nampoothiri; Auro Viswabandya
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-12       Impact factor: 0.915

6.  Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.

Authors:  Ana Espírito ESPíRITO Santo; Sérgio Chacim; Isabel Ferreira; Luís Leite; Claudia Moreira; Dulcineia Pereira; Margarida Dantas Dantas Brito; Marta Nunes; Nelson Domingues; Isabel Oliveira; Ilídia Moreira; Angelo Martins; Luísa Viterbo; José Mário Mariz; Rui Medeiros
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

7.  Paclitaxel Induced MDS and AML: A Case Report and Literature Review.

Authors:  Udit Bhaskar Bhatnagar; Daulath Singh; Alexy Glazyrin; Jill Moormeier
Journal:  Case Rep Oncol Med       Date:  2016-02-29

8.  Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Authors:  Masatoshi Matsuo; Masako Iwanaga; Hisayoshi Kondo; Midori Soda; Tatsuro Jo; Kensuke Horio; Yumi Takasaki; Yasuhisa Kawaguchi; Hideki Tsushima; Yoshitaka Imaizumi; Daisuke Imanishi; Jun Taguchi; Yasushi Sawayama; Tomoko Hata; Yasushi Miyazaki
Journal:  Cancer Sci       Date:  2016-09-02       Impact factor: 6.716

Review 9.  Mutagenic Consequences of Sublethal Cell Death Signaling.

Authors:  Christine J Hawkins; Mark A Miles
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

Review 10.  Therapy-related myeloid neoplasms: clinical perspectives.

Authors:  Luana Fianchi; Marianna Criscuolo; Emiliano Fabiani; Giulia Falconi; Alessio Maria Edoardo Maraglino; Maria Teresa Voso; Livio Pagano
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.